Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to find out if supervised exercise training using a treadmill with partial weight support is safe and has an impact on gait and function of persons with Amyotrophic lateral sclerosis.

Detailed Description
-----------------
Twenty ALS patients who are independent in their transfer with assistive devise such as walker, cane, or AFO will be offered the opportunity to participate in this study. 20 subjects will be enrolled at Carolinas ALS/Neuromuscular Center at the Carolinas HealthCare System. Eligible subjects will return for 26 sessions, each lasting between 1-2 hours. At Session 1 (4 weeks pre-treatment), assessments of muscle strength, spasticity, gait, and balance will be performed, which will take between 30-60 minutes. At Sessions 2-25, patients will do supported treadmill ambulation training at a very low speed 3 times a week for 6 weeks under the supervision of the physical therapist. Each session will have 30 minutes of direct ambulation with the suspension system and treadmill over a 60 minute period of time. Additionally, at sessions 13 and 26 (4 and 8 weeks post-treatment), the assessments of muscle strength, spasticity, gait, and balance will be repeated. Needle EMG to assess denervation potential will be performed at base line and at the conclusion of the study. The study will last a total of 26 weeks for each patient.

Official Title
-----------------
Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis

Conditions
-----------------
Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Lou Gehrig's Disease

Intervention / Treatment
-----------------
* Behavioral: Treadmill Exercise


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Clinically probable or definite diagnosis of ALS/MND Able to stand independently and ambulate for six minutes with their assistive devices Able to complete the 25 foot walk in less than 1 minute Vital Capacity of over 65% predicted 25 to 75 years of age Not a pregnant woman Able to provide informed consent and to comply with training and assessment procedures Exclusion Criteria: Unstable angina or severe left main coronary disease End-stage congestive heart failure Severe valvular heart disease Malignant or unstable arrhythmias Elevated resting blood pressure (systolic, 200mmHg; diastolic, 110mmHg) Large or expanding aortic aneurysm Known cerebral aneurysm or recent intracranial bleed Uncontrolled or end-stage systemic disease Acute retinal hemorrhage or recent ophthalmologic surgery Acute or unstable musculoskeletal injury

Ages Eligible for Study
-----------------
Minimum Age: 25 Years
Maximum Age: 75 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Prevention
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: supported treadmill ambulation training<br> | Behavioral: Treadmill Exercise<br>* The intervention will consist of 30 minutes of exercise, performed 3 times per week for 8 weeks (24 sessions). Patient will walk on a treadmill with up to 40% of their body weight supported by a body weight support system with an overhead harness. The training session duration will be 60 minutes consisting of six intervals of 5 minutes exercise, interspersed with 6 intervals of 5 minutes rest to avoid overwork weakness and fatigue. Five minute exercise intervals should be sufficient for patients to reach a steady state. Patients will build up their endurance to this training level at their own pace as tolerated. Walking speed will be determined as tolerated by each patient. Exercise intensity will be guided by each patient's own perception of exertion, but not to exceed level 12-13 (mild to moderate) on the modified Borg perceived exertion scale, and by oxygen saturation (Sa O2) ≥ 90% monitor by handheld pulse Oximeter.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Twenty Five Foot Walk Test (25FWT) |  | baseline, after 4 weaks and 8 weaks post training | 
| The Six-Minute Walk Test (6MWT) |  | baseline, after 4 weaks and 8 weaks post training | 
| Fatigue severity scale (FSS) |  | baseline, after 4 weaks and 8 weaks post training | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Muscle strength |  | baseline, after 4 weaks and 8 weaks post training | 
| ALS functional rating scale (ALSFRS-R) |  | baseline, after 4 weaks and 8 weaks post training | 
| Vital Capacity |  | baseline, after 4 weaks and 8 weaks post training | 
| Beck Depression Inventory (BDI) |  | baseline, after 4 weaks and 8 weaks post training | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Exercise for Amyotrophic lateral sclerosis